Please provide your email address to receive an email when new articles are posted on . Among patients who underwent a stress myocardial perfusion PET scan, increasing magnitude of stress myocardial ...
The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offsite pharmacy and delivered as a ready-to-use unit dose. The approval was supported by data from ...
BARCELONA, Spain ― Artificial intelligence (AI) software substantially reduced false positives on myocardial perfusion imaging (MPI) for the diagnosis of coronary artery disease in high-risk patients, ...
The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...
A new radioactive tracer for positron emission tomography (PET) myocardial perfusion imaging will soon be available in the United States, and it’s expected to facilitate substantial growth in such ...
The Society of Nuclear Medicine and Molecular Imaging (SNMMI), American Society of Nuclear Cardiology (ASNC), European Association of Nuclear Medicine (EANM), and American College of Nuclear Medicine ...
Photo Credit: Adapted from de Winter RW, et al. EuroIntervention. 2021;Epub ahead of print. Used with permission. Remote myocardial perfusion increases after revascularization of a chronic total ...
GlobalData on MSN
Philips advances cardiac MR with FDA clearance for SmartHeart AI
SmartHeart AI is a workflow planning solution designed to facilitate the application of tools within Philips’ broader cardiac MR suite.
The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offisite pharmacy and delivered as a ready-to-use unit dose. The Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results